Effectiveness of transcutaneous tibial nerve stimulation at home in overactive bladder symptoms compared to out-patient percutaneous tibial nerve stimulation.

Effectiveness of transcutaneous tibial nerve stimulation at home in overactive bladder symptoms compared to out-patient percutaneous tibial nerve stimulation. - Home treatment in overactive bladder symptoms (HOTOB).

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57821

Enrollment

Registered

2021-07-07

Start date

2022-01-25

Completion date

Unknown

Last updated

2026-07-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

1. Overactive bladder 2. hyperactive detrusor 3. frequent urgency for miction Overactive bladder

Interventions

The intervention group receives TTNS, the control group continues with PTNS.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years or older Clinical diagnosis of OAB Persisting overactive bladder symptoms after first line treatment Positive response to initial course of PTNS

Exclusion criteria

Exclusion criteria: History of anti-incontinence surgery Pregnancy Pacemaker or neurostimulator Neurogenic lower urinary tract symptoms Inability to fully understand study procedures Use of anticholinergic agents or selective *-3-adrenoceptor-agonist

Design outcomes

Primary

Measure	Time frame
Micturition frequency after six weeks, three months and six months.	—

Secondary

Measure	Time frame
Secondary outcomes include symptom severity through OAB-q SF and cost effectiveness.	—

Countries

Netherlands

Contacts

Public ContactJ van Brakel

Amphia Ziekenhuis

jvanbrakel@ampia.nl0765951367

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 23, 2026